Prevention of acute and delayed chemotherapy-induced nausea and vomiting in pediatric cancer patients: A clinical practice guideline

Affiliations

• ¹ Pediatric Oncology Group of Ontario, Toronto, Canada.
• ² Department of Pharmacy, The Hospital for Sick Children, Toronto, Canada.
• ³ Not applicable (patient representative).
• ⁴ Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
• ⁵ Division of Haematology/Oncology, McMaster Children's Hospital, Hamilton, Canada.
• ⁶ College of Pharmacy, University of New Mexico, Albuquerque, New Mexico, USA.
• ⁷ Birmingham Women's and Children's Hospital, Birmingham, UK.
• ⁸ Division of Pediatric Hematology/Oncology, Connecticut Children's Medical Center, Hartford, Connecticut, USA.
• ⁹ Department of Pediatrics, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
• ¹⁰ Department of Haematology and Oncology, Leeds Teaching Hospital, NHS Trust, Leeds, UK.
• ¹¹ Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
• ¹² Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands.
• ¹³ University of California, Davis Health, Pediatric Hematology/Oncology, Davis, California, USA.
• ¹⁴ Department of Paediatrics, Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Canada.
• ¹⁵ Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, Toronto, Canada.
• ¹⁶ Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada.